F-group (family)
5.1.3.21 Fungal_lectin
Ligands and drugs
297
Member domains
276
with ligand contacts (≤ 4 Å)
92.9% of members
231
with DrugDomain annotations
77.8% of members
192
with a DrugBank compound
64.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5.1.3.21 belongs to X-group 5 beta-propeller-like, which binds 7.8 ligand superclasses per 20 proteins, broader than 52% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03879 | MFU | alpha-L-methyl-fucose | 55 |
| DB02561 | BDF | Beta-D-Fructopyranose | 36 |
| DB04473 | FUC | alpha-L-fucose | 33 |
| DB03283 | FUL | beta-L-fucose | 16 |
| DB00145 | GLY | Glycine | 8 |
| DB03252 | DLY | D-Lysine | 5 |
| DB03194 | MFB | Methyl beta-L-fucopyranoside | 4 |
| DB03709 | BCN | Bicine | 2 |
| DB03309 | NHE | N-cyclohexyltaurine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| BDF | beta-D-fructopyranose | 75 |
| MFU | methyl alpha-L-fucopyranoside | 55 |
| QQ7 | cucurbit[7]uril | 49 |
| FUC | alpha-L-fucopyranose | 32 |
| ZNmetal | ZINC ION | 30 |
| EVB | sulfonato-calix[8]arene | 22 |
| FUL | beta-L-fucopyranose | 15 |
| T3Y | 25,26,27,28-tetrahydroxypentacyclo[19.3.1.1~3,7~.1~9,13~.1~15,19~]octacosa-1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-dodecaene-5,11,17,23-tetrasulfonic acid | 13 |
| A1IXG | phosphated-cyclotrixylohydroquinoylene | 12 |
| BMA | beta-D-mannopyranose | 12 |
| FSW | methyl 6-deoxy-2-Se-methyl-2-seleno-alpha-L-galactopyranoside | 12 |
| NAmetal | SODIUM ION | 12 |
| GLY | GLYCINE | 8 |
| MRD | (4R)-2-METHYLPENTANE-2,4-DIOL | 7 |
| SFU | methyl 1-seleno-alpha-L-fucopyranoside | 7 |
| 7AZ | phosphonato-calix[6]arene | 6 |
| A1IZO | sulfato-terphen[3]arene complex | 6 |
| QJB | 2-[(2~{S},3~{S},4~{R},4~{a}~{S},10~{a}~{S})-2-methyl-3,4-bis(oxidanyl)-3,4,4~{a},10~{a}-tetrahydro-2~{H}-pyrano[2,3-b][1,4]benzoxathiin-7-yl]-~{N}-(3-oxidanylpropyl)ethanamide | 6 |
| R2F | 2-[2-[4-[[(2R,3S,4R,5S,6S)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-1,2,3-triazol-1-yl]ethoxy]ethyl 2-[3,6-bis(diethylamino)-9H-xanthen-9-yl]benzoate | 6 |
| ZDC | 3,7-anhydro-2,8-dideoxy-L-glycero-D-gluco-octonic acid | 6 |